The latest industry report published by Credence Research, Inc. “Global 3D Bioprinters industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the 3D bioprinters industry was valued at USD 562.8 Mn in 2015, and is expected to reach USD 1,942.5 Mn by 2022, expanding at a CAGR of 18.8% from 2016 to 2022.
3D bioprinting is the process that allows researchers to generate and assemble cellular layers to form organic tissues. The use of biomaterial cells, proteins or other biological compounds as building block is carried out for fabricating 3D personalized structures or in vitro biological models through additive manufacturing processes. The major factors driving 3D bioprinters industry are increasing demand for organ transplants, and requirement of cost-efficient technologies in drug development. According to the Organ Procurement and Transplantation Network (OPTN) and the Gift of Life Donor Program, in the U.S., an average of 21 people die every day waiting for an organ transplant, and the wait times can range from four months for a heart to five years for a kidney. 3D bioprinters industry
Browse the full report 3D Bioprinters industry – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/3d-bioprinters-market
The global 3D bioprinters industry is represented by key technologies namely, syringe based 3D bioprinting, laser based 3D bioprinting, magnetic levitation 3D bioprinting, inkjet based 3D bioprinting and valve-based 3D bioprinting. Among these syringe based 3D bioprinting is the largest segment and is anticipated to maintain its lead during the forecast period 2016 – 2022. Pharmaceuticals segment accounted for a major share of 31.70% in the 3D bioprinting industry. Drug development today is increasingly focusing on reducing side effects, improving treatment outcomes and deserting the ‘one-size-fits-all’ approach to medication management.
Request Free Sample: http://www.credenceresearch.com/sample-request/57766
Industry Competition Assessment
According to industry experts competition in 3D bioprinting industry is low and barriers are high. Competition is low due to presence of niche opportunities in the healthcare industry and barriers are high because the research is very specialized and requires a significant amount of investment, usually by the government or private donors, while the risks to profitability remain very high. 3D Systems, Inc. and Stratasys Ltd. dominate the 3D printer applications in healthcare industry. The other upcoming key players such as Organovo, Inc. and EnvisionTEC, Inc. are expected to be one of the leading players in 3D bioprinting industry in the near future.
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Name: Chris Smith
Designation: Global Sales Manager